Intuitive Surgical (NASDAQ: ISRG)‘s stock had its “buy” rating reiterated by equities research analysts at TheStreet in a research note issued to investors on Friday.

The analysts wrote, “Intuitive Surgical (ISRG) has been reiterated by TheStreet Ratings as a buy with a ratings score of A- . The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.”

A number of other firms have also recently commented on ISRG. Analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Intuitive Surgical in a research note to investors on Thursday. They now have a $625.00 price target on the stock. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Intuitive Surgical from $550.00 to $575.00 in a research note to investors on Monday. Finally, analysts at Cantor Fitzgerald upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note to investors on Monday.

Eleven analysts have rated the stock with a buy rating, one has assigned an overweight rating, five have given a hold rating, and two have issued a sell rating to the stock. The stock presently has a consensus rating of “overweight” and a consensus price target of $615.00.

Shares of Intuitive Surgical (NASDAQ: ISRG) traded down 5.04% during mid-day trading on Friday, hitting $465.18. Intuitive Surgical has a one year low of $467.26 and a one year high of $594.89. The stock’s 50-day moving average is currently $555.9. The company has a market cap of $18.666 billion and a P/E ratio of 30.66.

Intuitive Surgical (NASDAQ: ISRG) last released its earnings data on Tuesday, January 22nd. The company reported $4.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.02 by $0.23. The company had revenue of $609.30 million for the quarter, compared to the consensus estimate of $584.36 million. During the same quarter in the previous year, the company posted $3.75 earnings per share. The company’s revenue for the quarter was up 22.6% on a year-over-year basis. Analysts expect that Intuitive Surgical will post $17.56 EPS for the current fiscal year.

Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.

To view TheStreet’s full report, visit www.thestreetratings.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.